<DOC>
	<DOCNO>NCT02863549</DOCNO>
	<brief_summary>The aim study investigate procedural feasibility 30-day result transcatheter tricuspid valve repair use MitraClipÂ® system ( Abbott Vascular ) select , highly symptomatic patient severe tricuspid regurgitation ( TR ) .</brief_summary>
	<brief_title>MitraClip Severe TR</brief_title>
	<detailed_description>The primary objective prospective analysis determine feasibility term success rate short-term clinical follow-up 30 day . In context procedural success define reduction least one TR grade . At 30-days procedure , clinical follow perform heart failure outpatient clinic department include transthoracic echocardiography evaluation TR grade . Furthermore , investigator determine NYHA functional class incidence major adverse cardiac cerebrovascular event ( MACCE ) . Secondary objective assessment right ventricular function , 6-minute walk distance , NT-proBNP well quality life assess Minnesota Living Heart Failure Questionnaire ( MLHFQ ) score 30-days follow .</detailed_description>
	<mesh_term>Tricuspid Valve Insufficiency</mesh_term>
	<criteria>rightsided heart failure due moderatetosevere tricuspid regurgitation patient deem inoperable heart Team poor Echoimage quality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>